Bioactivities of ethanol extract from the antarctic freshwater microalga, chloromonas sp

International Journal of Medical Sciences

Volumn 14, Issue 6, 2017, Pages 560-569

  Suh, Sung Suk ^a   Yang, Eun Jin ^b   Lee, Sung Gu ^a   Youn, Ui Joung ^a   Han, Se Jong ^a   Kim, Il Chan ^a   Kim, Sanghee ^a  

^a Korea Polar Research Institute (KOPRI)   (South Korea)

^b Department of Polar Ocean Environment   (South Korea)

Author keywords

Bioactivities; Chloromonas sp; Ethanol extract

Indexed keywords

ALGAL EXTRACT; ASCORBIC ACID; CASPASE 3; PROTEIN BCL 2; PROTEIN P53; ALCOHOL; PLANT EXTRACT;

A-375 CELL LINE; ABTS RADICAL SCAVENGING ASSAY; ANTARCTICA; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; BREAST CANCER CELL LINE; CANCER INHIBITION; CHLOROMONAS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DPPH RADICAL SCAVENGING ASSAY; FRESHWATER SPECIES; HELA CELL LINE; HUMAN; HUMAN CELL; IN VITRO STUDY; KERATINOCYTE CELL LINE; METASTASIS INHIBITION; MICROALGA; NONHUMAN; PROTEIN CLEAVAGE; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECTS; NEOPLASM; PATHOLOGY;

ANTARCTIC REGIONS; APOPTOSIS; CELL PROLIFERATION; ETHANOL; HELA CELLS; HUMANS; MICROALGAE; NEOPLASMS; PLANT EXTRACTS;

EID: 85019577674     PISSN: 14491907     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijms.18702     Document Type: Article

References (32)

1. Mantovani A, Allavena P. The interaction of anticancer therapies with tumor associated macrophages. J Exp Med. 2015; 212: 435-45.
2. Gore L, DeGregori J, Porter CC. Targeting developmental pathways in children with cancer: what price success?. Lancet Oncology 2013; 4: e70-8.
3. Dossett LA, Kudchadkar RR, Zager JS. BRAF and MEK inhibition in melanoma. Expert Opin Drug Saf. 2015; 14: 559-70.
4. Kato S, Moulder SL, Ueno NT, Wheler JJ, Meric-Bernstam F, Kurzrock R, et al. Challenges and perspective of drug repurposing strategies in early phase clinical trials. Oncoscience. 2015; 2: 576-80.
5. Vazquez A. Optimization of personalized therapies for anticancer treatment. BMC Syst Biol. 2013; 7: 31.
6. Basmadjian C, Zhao Q, Bentouhami E, Djehal A, Nebigil CG, Johnson RA, et al. Cancer wars: natural products strike back. Front Chem. 2014; 2: 20.
7. Sawadogo WR, Boly R, Cerella C, Teiten MH, Dicato M, Diederich M. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2012. Molecules. 2015; 20: 7097-142.
8. Orang-Ojong BB, Munyangaju JE, Wei MS, Lin M, Wei FG, Foukunang C, et al. Impact of natural resources and research on cancer treatment and prevention: A perspective from Cameroon. Mol Clin Oncol. 2013; 1: 610-20.
9. Ko JK, Auyeung KK. Identification of functional peptides from natural and synthetic products on their anticancer activities by tumor targeting. Curr Med Chem. 2014; 21: 2346-56.
10. Giddings LA, Newman DJ. Microbial natural products: molecular blueprints for antitumor drugs. J Ind Microbiol Biotechnol. 2013; 40: 1181-210.
11. Younis KM, Usup G, Ahmad A. Secondary metabolites produced by marine Streptomyces as antibiofilm and quorum-sensing inhibitor of uropathogen Proteus mirabilis. Environ Sci Pollut Res Int. 2016; 23: 4756-67.
12. Cragg GM, Grothaus PG, Newman DJ. Impact of natural products on developing new anti-cancer agents. Chem Rev. 2009; 109: 3012-43.
13. Gimpel JA, Henríquez V, Mayfield SP. In metabolic engineering of eukaryotic microalgae: potential and challenges come with great diversity. Font Microbiol. 2015; 6: 1376.
14. Sharma NK, Rai AK. Biodiversity and biogeography of microalgae: progress and pitfalls. Environ Rev. 2011; 19: 1-15.
15. Shanab SM, Mostafa SS, Shalaby EA, Mahmoud GI. Aqueous extracts of microalgae exhibit antioxidant and anticancer activities. Asian Pac J Trop Biomed. 2012; 2: 608-15.
16. de Morais MG, Vaz Bda S, de Morais EG, Costa JA. Biologically active metabolites synthesized by microalgae. Biomed Res Int. 2015; 2015: 1-15.
17. Martins A, Vieira H, Gaspar H, Santos S. Marketed marine natural products in the pharmaceutical and cosmeceutical industries: tips for success. Mar Drugs. 2014; 12: 1066-101.
18. Dias DA, Urban S, Roessner U. A historical overview of natural products in drug discovery. Metabolites. 2012; 2: 303-36.
19. David B, Wolfender JL, Dias DA. The pharmaceutical industry and natural products: historical status and new trends. Phytochem Rev. 2015; 14: 299-315.
20. Lee JC, Hou MF, Huang HW, Chang FR, Yeh CC, Tang JY, et al. Marine algal natural products with anti-oxidative, anti-inflammatory, and anti-cancer properties. Cancer Cell Int. 2013; 13: 55.
21. Farooqi AA, Butt G, Razzaq Z. Algae extracts and methyl jasmonate anti-cancer activities in prostate cancer: choreographers of ‘the dance macabre’. Cancer Cell Int. 2012; 12: 50.
22. Talero E, García-Mauriño S, Ávila-Román J, Rodríguez-Luna A, Alcaide A, Motilva V. Bioactive compounds isolated from microalgae in chronic inflammation and c ancer. Mar Drugs. 2015; 13: 6152-209.
23. Kumar SR, Hosokawa M, Miyachita K. Fucoxanthin: a marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms. Mar Drugs. 2013; 11: 5130-47.
24. Takahashi K, Hosokawa M, Kasajima H, Hatanaka K, Kudo K, Shimoyama N, et al. Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues. Oncol Lett. 2015; 10: 1463-7.
25. Peng J, Yuan JP, Wu CF, Wang JH. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: metabolism and bioactivities relevant to human health. Mar Drugs. 2011; 9: 1806-28.
26. Brand-Williams W, Cuvelier ME, Berset C. Use of a free radical method to evaluate antioxidant activity. Food Sci Technol. 1995; 28: 25-30.
27. Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radic Biol Med. 1999; 26: 1231-7.
28. van Zijl F, Krupitza G, Mikulits W. Initial steps of metastasis: Cell invasion and endothelial transmigration. Mutat Res. 2011; 728: 23-34.
29. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol. 2007; 35: 495-516.
30. Danial NN. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res. 2007; 13: 7254-63.
31. Amaral JD, Xavier JM, Steer CJ, Rodrigues CM. The role of p53 in apoptosis. Discov Med. 2010; 9: 145-52.
32. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res. 2000; 45: 528-37.